Post-infarction ventricular septal defect

Article written and reviewed by Dr Luca Moretti

A post-infarction ventricular septal defect is an acquired laceration of the necrotic interventricular septum that creates a communication between the two chambers. Higher left ventricular pressure drives oxygenated blood into the right ventricle, diverting it from systemic output and sending it back to the lungs. The left-to-right shunt creates an inefficient hemodynamic circuit. Within hours, the consequence may progress from an isolated murmur to biventricular failure and shock.
This lesion is also called ventricular septal rupture, whereas the term defect describes the resulting communication. It is not comparable to a congenital defect: its margins are irregular and necrotic and may disintegrate after diagnosis, making dimensions and trajectory dynamic; post-infarction friability affects both surgery and transcatheter closure. Devices designed for healthy congenital tissue do not behave in the same way in acutely infarcted myocardium.

Presentation depends on location, effective diameter, tortuosity, systemic and pulmonary resistance, and function of both ventricles. A small defect may initially be tolerated but expand; a large one may cause immediate collapse, while a complex posterior tract may be difficult to measure in one plane. Hemodynamic severity does not correspond to echocardiographic diameter alone. Pressures, Qp/Qs, perfusion, and clinical course must be interpreted together.
Suspicion should arise with a new murmur, thrill, dyspnea, pulmonary edema, hypotension, or right-sided failure after infarction. Bedside echocardiography with color Doppler is decisive and must simultaneously assess mitral regurgitation, tamponade, right ventricular infarction, and global function; immediate diagnosis activates a cardiac surgical and structural pathway. Medical therapy may stabilize temporarily but does not eliminate the communication.

Epidemiology, etiology, and predisposing factors

Before reperfusion, septal rupture complicated approximately 2% of infarctions; fibrinolysis and especially primary PCI have reduced incidence to a few cases per thousand. Contemporary studies report different values according to population, selected STEMI, shock, and presentation delay, but agree on rarity and high residual mortality. Contemporary incidence is below 1%. The smaller number of cases concentrates expertise and outcomes in centers with multidisciplinary experience.
The anatomical prerequisite is transmural septal infarction caused by occlusion of perforating branches of the left anterior descending artery or of the right or circumflex artery through the posterior descending artery. Absence of collaterals and a single culprit vessel may leave a uniformly vulnerable territory. Septal ischemia must be deep enough to interrupt the supporting structure. A perfusion defect alone is not equivalent to rupture.

Advanced age, female sex, STEMI, complete occlusion, high Killip class, and late presentation recur in cohorts. Previous infarction, angina, or multivessel disease may be associated with protective collaterals, but these relationships are observational and cannot reassure an individual; clinical predictors identify populations, not exempt patients. Deterioration after any infarction requires echocardiography regardless of profile.
Timely reperfusion reduces infarct size and overall risk. When rupture occurs after PCI or fibrinolysis, intramyocardial hemorrhage, dissection, and abrupt changes in contractile force in the border zone may contribute to early presentation; this does not diminish the population benefit of reperfusion. Early rupture may reflect an infarction already advanced on arrival. Symptom time and vessel-opening time must be documented separately.

Anterior infarctions more often cause relatively direct apical or anterior defects; inferior infarctions may produce basal posterior, serpiginous lesions associated with right ventricular involvement. The latter phenotype often has more complex anatomy and worse outcomes, but substantial overlap exists. Coronary location foreshadows the tract without defining it completely. Multiplanar imaging is essential before selecting access and technique.
The COVID-19 pandemic showed how delayed access can cause mechanical complications to reemerge: European cohorts observed more late presentations and a numerical increase in septal ruptures. The association does not prove a direct viral effect but emphasizes dependence on the ischemic interval. Delay in care is a modifiable determinant. Symptom recognition and activation of STEMI networks prevent more effectively than late surveillance.

Once the breach has formed, systemic hypertension, vasoconstriction, and hypercontractility increase the gradient and shunt, whereas pulmonary hypertension or severe right-sided failure may limit it at the cost of very low output. A softer murmur therefore does not necessarily mean improvement; loading conditions continuously modify the phenotype. Every serial comparison must consider drugs, ventilation, and active support.
Prevention depends on rapid reperfusion, infarct control, and monitoring during the first days. No pharmacological therapy can selectively reinforce the necrotic septum; rest, controlled pressure, and ischemia treatment may reduce stress but cannot guarantee that laceration will not develop. Structural prevention coincides with early myocardial salvage. After diagnosis, the goal changes from prevention to stabilization toward closure.

Pathological anatomy, classification, and pathophysiology

Necrosis, edema, hemorrhage, and inflammatory infiltration disrupt alignment of septal fibers. Failure may be a direct perforation or follow planes of intramyocardial dissection, creating multiple entries, cavities, and exits toward the right ventricle; the orifice visualized by color Doppler may therefore represent only part of the lesion. The septal tract may be tortuous and three-dimensional; this complexity explains discordant measurements among echocardiography, CT, surgery, and device sizing.
Anterior defects are often apical, simple, and associated with left anterior descending infarction. Posterior or inferior defects tend to be basal, irregular, and close to the tricuspid valve, mitral apparatus, and free wall; right ventricular infarction or papillary rupture may coexist; the posterior defect requires particularly careful planning. Proximity to valvular structures limits oversized patches and occluder devices.

Flow predominantly follows the left-to-right gradient during systole. Diverted volume depends on effective defect area, the ratio of systemic to pulmonary vascular resistance, ventricular pressure, and chamber compliance; systemic vasoconstriction may increase the shunt fraction; the Qp/Qs ratio quantifies pulmonary relative to systemic flow. A high value documents substantial recirculation but does not alone summarize perfusion or right ventricular function.
The right ventricle suddenly receives blood from the left ventricle in addition to normal venous return. Pressure and volume rise, the septum loses its normal contribution, and right coronary perfusion may become inadequate; tricuspid annular dilation adds regurgitation and congestion. Right ventricular failure is a central prognostic issue. Once present, support focused only on the left ventricle may be inadequate.

Shunted blood passes through the lungs and returns to the left atrium and ventricle, increasing preload and filling pressure. Although left systolic function may appear preserved or hyperdynamic, part of output does not reach the aorta; pulmonary congestion and hypoperfusion may therefore coexist; ineffective output distinguishes total from systemic output. Ejection fraction does not measure this diversion.
The sympathetic response increases heart rate and peripheral resistance to maintain pressure. Higher left afterload diverts an additional fraction of flow into the right ventricle, amplifying the circuit; acidosis, hypoxia, and ischemia then worsen biventricular function and vasoreactivity; the vicious cycle leads to progressive shock. Afterload reduction can interrupt it only if blood pressure permits safe vasodilation.

Tissue continues to change after diagnosis. Lysis of necrotic myocardium may enlarge the orifice, create new fenestrations, or move the margins relative to a prosthesis; subsequent organization and fibrosis make tissue more able to hold sutures or devices. Anatomical evolution fuels controversy over closure timing. Waiting improves consistency but exposes the patient to expansion, shock, and death before intervention.
After closure, a small residual jet may be hemodynamically tolerated, whereas a large passage maintains hemolysis, congestion, and right-sided overload. Dehiscence may result from progression of marginal necrosis, patch tension, or inadequate device sizing; the residual shunt must be quantified, not merely described. Its significance depends on output, pressures, hemolysis, and ventricular recovery capacity.

Clinical manifestations

The classic presentation is a new harsh holosystolic murmur along the lower sternal border, often accompanied by a palpable thrill. Intensity depends on gradient and output: in advanced shock the murmur may diminish despite a larger lesion, so physical examination must not become an exclusion criterion. A post-infarction murmur mandates immediate echocardiography. Direction or radiation does not always distinguish a defect from acute mitral regurgitation.
Dyspnea, tachypnea, hypoxemia, crackles, and pulmonary edema reflect increased pulmonary flow and pressure. Congestion may be less prominent when right-sided failure predominates or when output is so low that it limits the shunt, in which case hypotension and oliguria dominate; the respiratory phenotype varies with biventricular balance. A relatively clear chest does not exclude a severe communication.

Shock manifests with cold skin, altered mental status, oliguria, rising lactate, and reduced pulse pressure. Arterial pressure maintained by vasopressors may mask worsening systemic output, while increasing doses may raise afterload and the shunt; organ perfusion matters more than mean pressure alone. Lactate trend, urine output, and venous saturation should guide escalation of support.
Signs of right-sided failure include jugular distension, hepatomegaly, systemic congestion, and worsening renal function. An inferior infarction may simultaneously cause right ventricular necrosis and a posterior defect, making fluid response more fragile and increasing the risk of inadequate support; right-sided involvement worsens operative prognosis. Echocardiography and catheterization must distinguish shunt overload from primary ventricular infarction.

Timing is variable, with cases during the first 24 hours and another group over subsequent days. A patient may initially be stable with a small defect and deteriorate through expansion, persistent ischemia, or exhaustion of compensation; serial assessments are essential after the first sign; rapid progression is part of the natural history. A reassuring assessment is no longer valid after a clinical change.
Chest pain may persist because of ischemia or infarct extension but is not specific to rupture. Palpitations and syncope may result from arrhythmia, while fever and leukocytosis may reflect necrosis without infection; none should distract from structural analysis; associated symptoms help measure severity, not localize the breach. History must reconstruct the intervals among infarction, reperfusion, and deterioration.

The principal clinical differential diagnosis is papillary muscle rupture, which causes pulmonary edema and shock with an apical murmur that may be subtle. Free-wall rupture causes tamponade, whereas right ventricular infarction and shock from myocardial loss do not create a new shunt; multiple complications may coexist; echocardiographic comparison must examine the septum, mitral valve, and pericardium in the same scan. Attributing the condition to one lesion before imaging is hazardous.
Some patients remain normotensive with moderate dyspnea and preserved organ function; this stability provides time for imaging and planning but does not guarantee a benign course because the defect may expand without warning; intensive care admission and immediate access to repair remain necessary; apparent stability is a therapeutic window. It is not an automatic indication for prolonged waiting.

Investigations, diagnosis, and differential diagnosis

Transthoracic echocardiography with color Doppler identifies the jet through the septum and defines location, direction, apparent dimensions, velocity, and chambers involved. It must measure left and right ventricular function, pulmonary pressures, tricuspid and mitral regurgitation, pericardial effusion, and other mechanical defects. Color Doppler is the initial diagnostic method. Nyquist scale adjustment and multiple planes prevent underestimation of eccentric or tortuous jets.
Two-dimensional measurement may underestimate an irregular defect and does not always distinguish the left-sided entry, dissected cavity, and right-sided exit. Three-dimensional echocardiography, contrast, and TEE improve reconstruction, especially for posterior defects and planning of patches or occluder devices. Three-dimensional anatomy determines closure feasibility. Device size must not derive from one unstable diameter.

Right heart catheterization documents pressures, output, and the oxygen saturation step-up between the right atrium and right ventricle. Qp/Qs quantifies shunt magnitude, while cardiac index and cardiac power help describe shock; oxygen, ventilation, and support may alter measurements; the oximetric step-up confirms passage at ventricular level. Catheterization must not delay urgent intervention already indicated by echocardiography.
Coronary angiography defines the culprit vessel, flow, and nonculprit disease. It may already be available from primary PCI; otherwise, the need to obtain it depends on stability and surgical strategy because added time may be harmful; the coronary picture informs selective revascularization. Left ventriculography is unnecessary when the defect is well defined and may increase contrast load.

ECG-gated cardiac CT offers reconstructions of the tract, margin thickness, and relationships with valves and arteries, useful for transcatheter closure or complex anatomy. CMR quantifies shunt and viable tissue, but both require stability, transport, and time and are not first-choice tests in shock. Advanced imaging is reserved for concrete procedural questions. Serial echocardiography remains the most accessible method for following evolution.

Essential information before selecting a closure strategy

• Location and tract: apical, anterior, posterior, or basal, simple or serpiginous.
• Dynamic dimensions: left and right orifices, dissected cavities, and serial change.
• Hemodynamic impact: Qp/Qs, systemic output, pulmonary pressures, and filling.
• Biventricular function: left-sided injury, right-sided failure, and associated valvular regurgitation.
• Anchoring tissue: distance from valves, viable margins, and risk of expansion.

Blood tests assess lactate, renal and hepatic function, blood count, coagulation, troponin, and acid-base status. Troponin does not distinguish rupture from uncomplicated infarction; rising lactate and organ dysfunction indicate that the window for a deferred strategy is closing; perfusion markers guide intervention timing more than defect age alone. They must be repeated after every support change.
The differential diagnosis includes acute mitral regurgitation, free-wall rupture, right ventricular infarction, endocarditis with an acquired defect, a preexisting congenital defect, and iatrogenic communications. Echocardiography identifies the shunt level, while history and morphology distinguish an organized congenital rim from recent necrotic margins. Acquired origin is supported by correspondence with the infarct territory. Multiple mechanical lesions may require combined repair.

Serial monitoring must not be limited to repeating maximum diameter. Each assessment should compare arterial pressure, vasoactive dose, diameters of both orifices, flow direction and velocity, Qp/Qs, right ventricular function, pulmonary pressure, and signs of congestion; reduced velocity may indicate a smaller gradient because of shock rather than anatomical improvement. Longitudinal interpretation prevents conclusions contrary to physiology. Images and hemodynamic conditions must be stored together for multidisciplinary discussion.

Stabilization, definitive treatment, and prognosis

The patient must be transferred to or managed at a center with cardiac surgery, structural intervention, intensive care, and support capability. The 2025 US guidelines prioritize management at facilities with cardiac surgical expertise; multidisciplinary discussion begins at diagnosis, not after pharmacological failure. The multidisciplinary team defines closure, bridging, and limits of care. Every strategy must include a rescue pathway if hemodynamics change.
In normotensive patients, nitroprusside or other titratable vasodilators can reduce systemic resistance and the shunt fraction, improving forward output. Diuretics treat congestion and noninvasive or invasive ventilation supports gas exchange; in hypotension, vasopressors are used at the lowest effective dose to preserve organs. Afterload reduction is limited by available pressure. Aggressive vasodilation during shock may precipitate collapse.

The IABP reduces systolic afterload and increases diastolic pressure, potentially reducing the shunt and supporting coronary perfusion; it remains the most commonly used device in series, but no specific randomized studies demonstrate a survival benefit. Limb ischemia, bleeding, and aortic regurgitation limit its use. The intra-aortic balloon pump is a selective bridge. Response must be verified through output, Qp/Qs, and perfusion, not pressure alone.
A microaxial pump may unload the left ventricle and reduce the gradient across the defect, but flow depends on right-sided preload and a large shunt or right-sided failure may cause suction events and instability. VA-ECMO supports perfusion and oxygenation but increases left ventricular afterload, potentially aggravating shunt and congestion unless appropriate unloading is added. Support selection requires individual physiology. No device is a universal or risk-free solution.

Guidelines consider temporary support as a bridge to surgery reasonable in appropriate patients, but evidence is predominantly nonrandomized. An effective bridge must improve lactate, organ function, and conditions for closure without expanding the defect, causing hemolysis, or becoming indefinite waiting. The bridge to repair has verifiable daily goals. If stabilization fails, intervention cannot be postponed according to the calendar.
Surgical patch closure remains the reference treatment for most patients. Techniques include infarct excision and closure, exclusion of the necrotic area with a patch, and double-patch variants; anterior or posterior location determines ventriculotomy and trajectory. Infarct exclusion aims to anchor to stronger tissue. The technique is adapted to margins, ventricular function, and associated lesions.

Surgical timing is controversial. Deferral permits tissue organization and is associated with lower mortality in cohorts, but comparison is strongly biased because only patients stable enough survive to delayed surgery; shock, expansion, and organ failure require early repair. Individualized timing prevails over rigid seven-day thresholds. True stability and trajectory matter more than elapsed time in the abstract.
Transcatheter closure uses dedicated or adapted occluder devices and may be primary in favorable anatomy, an alternative with prohibitive surgical risk, a bridge to surgery, or treatment for a residual shunt. In the acute phase, friable margins, large or posterior defects, and valve proximity increase embolization, interference, and residual passage. Percutaneous closure requires expert imaging and operators. Technical success does not always mean recovery from advanced shock.

During a transcatheter procedure, fluoroscopic and echocardiographic guidance controls crossing, capture of margins, and relationships with valvular apparatuses. Device selection accounts for an echocardiographic defect that may be smaller than the necrotic zone and for excessive oversizing that may tear the septum or obstruct nearby structures; shunt, stability, and new regurgitation are checked before release. The positioning trial must remain reversible until relationships are safe. A second device may correct fenestrations but increases complexity and risk.
Concomitant bypass is assessed according to multivessel disease, viable territory, and operative cost. Pooled analyses of mechanical complications do not demonstrate a uniform advantage, whereas revascularizing at-risk nonculprit myocardium may be rational in selected cases; the culprit vessel may already supply completed necrosis. The coronary strategy must not be automatic. It must avoid both unnecessarily prolonged cardiopulmonary bypass and correctable residual ischemia.

Aggregate operative mortality remains near 38%, with higher values in shock, posterior defects, right-sided failure, and emergency surgery. Conservative treatment alone has mortality approaching totality in historical series; survivors to discharge, however, may have satisfactory long-term survival. The biphasic prognosis separates an extremely critical phase from possible late recovery. Futility assessment must consider neurological and multiorgan reversibility, not age alone.

Complications, surveillance, and follow-up

A residual shunt after surgery or device closure is common and may result from unrecognized fenestrations, dehiscence, or progression of necrosis. A small stable jet may be observed, whereas high Qp/Qs, congestion, hemolysis, or worsening right-sided function requires repeat percutaneous or surgical closure; the residual defect is followed with serial Doppler. The decision considers physiological impact, not merely the presence of a Doppler signal.
Mechanical hemolysis is promoted by high-velocity jets through small residual passages or around a device. Falling hemoglobin, increased LDH, reduced haptoglobin, hemoglobinuria, and kidney injury require confirmation of the source and correction of the shunt if clinically relevant. Intravascular hemolysis may be the first sign of incomplete closure. Transfusion without modifying the jet does not resolve the mechanism.

Right ventricular failure may persist despite elimination of the shunt because of concomitant infarction, previous overload, or lung injury. Management of preload, pulmonary pressure, oxygenation, and rhythm must avoid both hypovolemia and distension; temporary right ventricular support may be needed in selected cases. Right ventricular recovery determines weaning. Normalization of systemic pressure does not automatically demonstrate adequate right-sided function.
Low output, vasoplegia, arrhythmias, bleeding, and multiorgan failure complicate the perioperative course. Devices and circuits add limb ischemia, hemolysis, stroke, infection, and thrombosis; surveillance must actively seek these events and support must be removed as soon as it is no longer needed; support complications increase with duration and intensity. Every day requires reassessment of benefit, goal, and weaning potential.

Patches or occluder devices may interfere with the tricuspid or mitral valve, outflow tracts, and conduction system. Atrioventricular block, new regurgitation, or obstruction requires ECG and echocardiography; some conduction disorders regress, while others require permanent pacing; anatomical proximity predicts the type of complication. Device sizing and position must be verified before definitive release.
Incomplete revascularization, a large infarction, and remodeling may leave chronic systolic dysfunction, aneurysm, mitral regurgitation, and arrhythmic risk. After stabilization, heart failure therapies and secondary prevention compatible with blood pressure, renal function, and bleeding are applied; post-infarction remodeling continues beyond closure. Septal repair does not restore already necrotic myocardium.

Before discharge, a reference echocardiogram, oxygen saturation, biventricular function, and definition of any shunt are required. Subsequent assessments are brought forward for dyspnea, edema, hemolysis, a new murmur, or functional decline; CT or CMR resolves selected anatomical uncertainties; echocardiographic follow-up must be scheduled and comparable. Serial reports should state location, velocity, dimensions, and consequences of residual passage.
Cardiac rehabilitation, nutritional recovery, neurocognitive assessment, and psychological support complete care. Return to activity depends on function, arrhythmias, repair stability, and exercise capacity, not only on time elapsed; shared decision-making reduces fear and inactivity. Functional prognosis may be good in survivors to discharge. Preventing new infarctions remains essential to preserve remaining myocardium.